SATELLOS BIOSCIENCE INC (MSCL.CA) Stock News
TSX-V:MSCL - TSX Venture Exchange - CA45107J1057 - Common Stock - Currency: CAD
MSCL.CA Latest News, Press Relases and Analysis
All
Press Releases
a year ago - Satellos Bioscience Inc.
Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy
Mentions: TSX
a year ago - Satellos Bioscience Inc.
Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange
Mentions: TSX
a year ago - Satellos Bioscience Inc.
Satellos Bioscience Announces 2023 Q3 Financial Results and Operational Highlights
Mentions: TSX
a year ago - Satellos Bioscience Inc.
Satellos to Present at the Piper Sandler 35th Annual Healthcare Conference
Mentions: TSX
1 years ago - Satellos Bioscience Inc.
Satellos Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program
Mentions: TSX
2 years ago - Satellos Bioscience Inc.
Satellos to Present at the Stifel 2023 Healthcare Conference
Mentions: TSX
4 years ago - TSX Venture Exchange
Satellos Virtually Opens the Market
4 years ago - Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions